sixteen patients - 12 with cutaneous t cell lymphoma ( ctcl ) , 1 with sezary syndrome , 1 with actinic reticuloid , and 2 with parapsoriasis variegata - were treated with either a new , potent arotinoid alone or with combined etretinate ( tigason ) and puva therapy ( re-puva ) .
C0015137
etretinate
C0729231
tigason